Bristol-Myers SquibbBMY 
$49.49-1.00%24h
-1.00%24h
Global rank146
Market cap$100.70B
Change 7d0.77%
YTD Performance-3.81%
SP500 benchmarkUnderperform
P/E0
P/S2.24
Revenue$45.01B
Earnings$8.04B
Dividend yield4.7%
Main Sector
Healthcare
Bristol-Myers Squibb BMY Total Debt
BMY Total Debt in 2022: $38.18B
According to Bristol-Myers Squibb latest financial reports the total debt is $38.18B, an increase of 5.14% to 2022. At the end of 2022 company had $36.32B total debt. This figure represents the debts and financial obligations that Bristol-Myers Squibb combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Bristol-Myers Squibb BMY Total Debt History from 2023 to 2022
-
Value:-
BMY Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $38.18B | 5.14% |
| 2022 | $36.32B | -10.28% |
| 2021 | $40.48B | -17.67% |
| 2020 | $49.17B | 11.60% |
| 2019 | $44.06B | 680.36% |
| 2018 | $5.65B | - |
View the Top Total Debt Stocks 
